Massachusetts 2025-2026 Regular Session

Massachusetts House Bill H3827 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 1 of 1
22 HOUSE DOCKET, NO. 2158 FILED ON: 1/15/2025
33 HOUSE . . . . . . . . . . . . . . . No. 3827
44 The Commonwealth of Massachusetts
55 _________________
66 PRESENTED BY:
77 Bruce J. Ayers
88 _________________
99 To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
1010 Court assembled:
1111 The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying
1212 resolution:
1313 Resolutions urging the Congress of the United States to update the Drug Addiction Treatment
1414 Act of 2000 and remove excessive training requirements mandated for obtaining a waiver to
1515 prescribe buprenorphine.
1616 _______________
1717 PETITION OF:
1818 NAME:DISTRICT/ADDRESS :DATE ADDED:Bruce J. Ayers1st Norfolk1/15/2025 1 of 3
1919 HOUSE DOCKET, NO. 2158 FILED ON: 1/15/2025
2020 HOUSE . . . . . . . . . . . . . . . No. 3827
2121 By Representative Ayers of Quincy, a petition (accompanied by resolutions, House, No. 3827) of
2222 Bruce J. Ayers for the adoption of resolutions by the General Court memorializing the Congress
2323 of the United States to update the Drug Addiction Treatment Act of 2000 and remove excessive
2424 training requirements mandated for obtaining a waiver to prescribe buprenorphine. Veterans and
2525 Federal Affairs.
2626 [SIMILAR MATTER FILED IN PREVIOUS SESSION
2727 SEE HOUSE, NO. 3486 OF 2023-2024.]
2828 The Commonwealth of Massachusetts
2929 _______________
3030 In the One Hundred and Ninety-Fourth General Court
3131 (2025-2026)
3232 _______________
3333 Resolutions urging the Congress of the United States to update the Drug Addiction Treatment
3434 Act of 2000 and remove excessive training requirements mandated for obtaining a waiver to
3535 prescribe buprenorphine.
3636 1 Whereas, since the 1990’s the United States of America has experienced a growing issue
3737 2of the overprescribing of opioid pain relievers; and
3838 3 Whereas, this overprescribing of opioids has led to dependence and addiction to drugs
3939 4such as heroin and fentanyl, which has resulted in a major public health crisis; and
4040 5 Whereas, in 2017, the United States Department of Health & Human Services declared
4141 6the opioid crisis a public health emergency; and
4242 7 Whereas, according to 2016 and 2017 data compiled by the Department of Health &
4343 8Human Services, more than 2.1 million people suffered from an opioid use disorder; and 2 of 3
4444 9 Whereas, in 2016 and 2017, an estimated 42,249 people died from overdosing on opioids;
4545 10and
4646 11 Whereas, according to the National Institute on Drug Abuse, more than 130 people per
4747 12day in the United States die after overdosing on opioids; and
4848 13 Whereas, national experts say these numbers will only continue to grow; and
4949 14 Whereas, in order to combat this growing epidemic, new methods of treatment must be
5050 15explored; and
5151 16 Whereas, Medically-Assisted Treatment has proven successful in reducing dependence
5252 17on opioids and treating addiction; and
5353 18 Whereas, buprenorphine is a medication used to treat opiate addiction; and
5454 19 Whereas, buprenorphine in combination with naxolone (Narcan) is Suboxone, a method
5555 20of Medically-Assisted Treatment in the form of a pill taken orally every 24 hours with the
5656 21potential to reduce symptoms of opiate addiction and withdrawal; and
5757 22 Whereas, buprenorphine is a Schedule III drug, meaning it carries “moderate to low
5858 23potential for physical and psychological dependence”; and
5959 24 Whereas, the Drug Addiction Treatment Act of 2000 stipulates that in order to prescribe
6060 25buprenorphine, a physician must complete an 8-hour training and take an exam, as well as obtain
6161 26a specific “X license” through the DEA; and
6262 27 Whereas, doctors may prescribe all other Schedule III drugs, as well as some Schedule II
6363 28drugs (with a “high potential for abuse, which may lead to psychological or physical 3 of 3
6464 29dependence”) utilizing their DEA license and without going through any special training or
6565 30obtaining any separate licenses; and
6666 31 Whereas, the requirements to prescribe buprenorphine are unreasonably stringent with no
6767 32precedent set in the prescribing of other Schedule III drugs; and
6868 33 Whereas, these unreasonable requirements are a deterrent for physicians to prescribe this
6969 34potentially life-saving drug; and
7070 35 Whereas, it is incumbent upon Congress to take every measure to treat drug addiction; be
7171 36it therefore
7272 37 Resolved, that The General Court urges the United States Congress to update the Drug
7373 38Addiction Treatment Act of 2000 to remove excessive training requirements mandated to
7474 39prescribe buprenorphine; and be it further
7575 40 Resolved, that copies of these resolutions be forwarded by the Clerk of the House to the
7676 41Vice-President of the United States, the Speaker of the House of Representatives and the
7777 42members of the Massachusetts Congressional delegation.